Our experience

Health

We have extensive experience, in addition to an extensive database, in all medical specialties, as well as in general medicine, nursing and even animal health.

We also have access to more complex audiences such as patients, payers/administrative departments, pharmaceutics and opinion leaders.

Studies conducted in different medical areas

  • Peanut allergy study. I nterviews with patients.
  • Narrative and lexical optimization to see what role type 2 inflammation plays in atopic dermatitis. Co-creative workshop with dermatologists and allergists
  • Study for building the optimal unbranded narrative to communicate the pivotal role that type 2 inflammation plays in atopic dermatitis with dermatologists and allergists.
  • Infusion pumps study. Interviews with anaesthesiologists.
  • Evaluation of bupivacaine in Europe for postoperative pain relief. Interviews with pharmacists, surgeons and anesthesiologists.
  • Study for understanding what are the unmet and/or under-served needs for patient interface masks used on patients receiving non-invasive ventilation (NIV) in the hospital. WATIs with nurses, department directors, Anaesthesiologists, Pulmonologists and Intensivists.
  • Qualitative study about food safety concern in beef in Europe. TDI with cattle producers, large size producers, retail buyers and responsible for meat purchase at larger grocery stores
  • Pre-test of the new packaging of a vaccine for pets. Personal interviews with companion animal veterinarians
  • Study to better understand use and perceptions of enzymes in poultry rations.
  • Face-to-face interviews with swine nutritionists and key opinion leaders, researchers / professors with knowledge of Enzyme use in swine
  • Study on the concerns in the care of dogs. Face-to-face focus groups with dog owners and veterinarians.
  • Qualitative analysis of the world of deworming of dogs and cats based on surveys conducted with veterinarians on leishmaniosis, as well as analysis of social networks.
  • Study for learning about current practices and procedures used to ensure safety of beef for consumption. Interview with cattle producers, retail buyers, processing managers and Key Opinion Leaders
  • Market comprehension study of monogastric enzymes. Interviews with veterinarians
  • Study on heart failure. Coordination of the recruitment of cardiologists
  • Analysis of the future panorama in the treatment of stable ischemic heart disease. Interviews with cardiologists
  • Study of therapies for Acutely Decompensated Heart Failure (ADHF). Interviews with Cardiology Department Head, Emergency Room Heads, AHF top Medical Experts (MEs), Hospital C-Level Executives and Exceptional funding source stakeholder
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH) study. Interviews with Pulmonologists, Cardiologists, Internal Medicine Specialist and Cardiothorasic Surgeons.
  • Study of treatment of the coronary artery disease and peripheral arterial disease patients discussing acute coronary event guidelines (ESC Guideline). TDIs with Cardiologists.
  • Study on the treatment of hyperlipidemia. Professional Advisory Groups with cardiologists, endocrinologists, internal medicine and GP’s
  • Analysis of the effect of covid-19 on the optimal commitment of the healthcare professional. WATIs with GPs, specialists in general medicine, pulmonologists, cardiologists and endocrinologists.
  • Plaque psoriasis study. TDI with dermatologists, nurses and pharmacists.
  • Study on a new treatment for atopic dermatitis (AD) in adolescents with dermatologists and pediatricians dermatologists.
    Narrative and lexical optimization to see what role type 2 inflammation plays in atopic dermatitis. Co-creative workshop with dermatologists and allergists
  • Study for building the optimal unbranded narrative to communicate the pivotal role that type 2 inflammation plays in atopic dermatitis with dermatologists and allergists.
  • Study about perceptions of the Alopecia Areata landscape and abaut a Unbranded Awareness Campaign. WATIs with regional and national payers in Spain.
  • Analysis of the effect of covid-19 on the optimal commitment of the healthcare professional. WATIs with GPs, specialists in general medicine, pulmonologists, cardiologists and endocrinologists.
  • Study of therapies for Acutely Decompensated Heart Failure (ADHF). Interviews with Cardiology Department Head, Emergency Room Heads, AHF top Medical Experts (MEs), Hospital C-Level Executives and Exceptional funding source stakeholder
  • Analysis of the experience of patients with human growth hormone treatment. In-depth interviews with patients and parents of patients.
  • Study on the diagnosis of osteoporosis in patients with diabetes / patients with osteoporosis treated with type 2 diabetes mellitus (T2DM). In-depth interviews with endocrinologists
  • Dialysis study. Interview with nephrologists and endocrinologists.
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Analysis of the therapeutic itinerary of acromegaly. Computer-assisted telephone interviews with endocrinologists.
  • Study on the treatment of hyperlipidemia. Professional Advisory Groups with cardiologists, endocrinologists, internal medicine and GP’s
  • Analysis of the effect of covid-19 on the optimal commitment of the healthcare professional. WATIs with GPs, specialists in general medicine, pulmonologists, cardiologists and endocrinologists.
  • Analysis of ulcerative colitis and Crohn’s disease, as well as prescription barriers and future forecast, with gastroenterologists
  • Study on non-alcoholic steatohepatitis, microbiome therapy and migraine therapy. Interviews with hepatologists, gastroenterologists, infectious disease specialists, neurologists, and general practitioners.
  • Understanding the management of patients with primary biliary cholangitis (PBC) treated with obeticholic acid, among gastroenterologists, hepatologists and internists
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Analysis of the hospital discharge moment in patients with dysphagia in Italy, the United Kingdom, Canada and Australia. Interviews with healthcare professionals and caregivers, as well as co-creation groups with the client.
  • Study for learning what it is like to live with ulcerative colitis. TDI’s with UC patients.
  • Study for the optimization of the communication message of a product for Crohn’s disease. Focus groups with gastroenterologists and strategic communication planning
  • Sensory pre-test of the new communication slogan of a brand of fruit salts. Dynamics in which people who usually have heaviness after eating, were invited to a copious meal and the subsequent use of fruit salts and a personal interview to test the slogan proposed for the brand
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Soundboard to sharpen the history of mortality and promote earlier intervention Work sessions with general practitioners in Belgium
  • Study about non-alcoholic steatohepatitis, microbiome therapy and migraine therapy. Interviews with hepatologists, gastroenterologists, infectious disease specialists, neurologists and general practitioners (GP).
  • Narcolepsy (Taciturn-R) study with HCPs and Patients
    Analysis of the effect of covid-19 on the optimal commitment of the healthcare professional. WATIs with GPs, specialists in general medicine, pulmonologists, cardiologists and endocrinologists.
  • Study on non-alcoholic steatohepatitis, microbiome therapy and migraine therapy. Interviews with hepatologists, gastroenterologists, infectious disease specialists, neurologists, and general practitioners.
  • Study on the treatment of hyperlipidemia. Professional Advisory Groups with cardiologists, endocrinologists, internal medicine and GP’s
  • Pre-test of communication materials for the campaign to launch a statin for the treatment of cholesterol. Focus groups with internists and primary care physicians
  • Test and optimization of concepts for the positioning of a brand of oral nutritional supplements (ONS). Focus groups rpesencailes with nutritionists, oncologists, geriatricians and internal medicine.
  • Strategic innovation study for healthy aging. Online interviews with consumers
  • Overactive Bladder (OAB) Study. Interviews with patients and professionals (GP/PCPs, Urologists, Gynecologists, Uro-Gynecologists, Prescribing Nurses, Physician’s Assistant,…).
  • Study of hormonal contraceptive intrauterine devices (IUDs) among women using contraception
  • Analysis of the oral contraceptives, with gynecologists.
  • Study for understanding the role of treatment for the management of VVA and inform the development of future communications. WATIs with gynecologists
  • Analysis of the osteoarticular pathology of the patient in Spain: structure and perceived quality. Interviews with social workers, care managers, nurses, occupational therapists, and gynecologists.
  • Study to understand the interaction between doctors and patients with hemophilia A. Interviews with hematologists, hematologists oncologists and patients
  • Study of the management of Paroxysmal nocturnal hemoglobinuria (PNH) patients. Interviews with haematologist and haematologist-oncologist.
  • Beta Thalassemia Physician Segmentation study, with hematologists, hematologists oncologists and patients.
  • Rapid Reversal of Anticoagulation study. Interviews with haematologists
  • Multicountry study about the treatment Pathway / Patient Journey Mapping for hemophelia, including gene therapy in Spain and Italy. Video interviews with hematologists, skatholders and hemophelia B patients.
  • Treatment for invasive candidiasis and candidemia positioning Testing. WATI’s con médicos de enfermedades infecciosas, especialistas en UCI y onco hematólogos en España.
  • Study for understanding the current market landscape for Prothrombin Complex Concentrate (PCC) with regards to its use as a reversal agent for Factor XA direct oral anticoagulants (DOACs). WATIs with haematologists.
  • Study on non-alcoholic steatohepatitis, microbiome therapy and migraine therapy. Interviews with hepatologists, gastroenterologists, infectious disease specialists, neurologists, and general practitioners.
  • Understanding the management of patients with primary biliary cholangitis (PBC) treated with obeticholic acid, among gastroenterologists, hepatologists and internists
  • Study for learning what it is like to live with ulcerative colitis. TDI’s with UC patients.
  • Understanding the out-patient setting in the serious fungal infections. WATI’s with Infectious disease HCPs, ICU Specialists and Heam Oncs in Spain.
  • Treatment for invasive candidiasis and candidemia positioning Testing. WATI’s con médicos de enfermedades infecciosas, especialistas en UCI y onco hematólogos en España.
  • Study to better understand the management of Covid-19 patients. TDI with generalist / primary care physicians, emergency (ER) Specialists, Senior Level payer and Point-of-care coordinator
  • Analysis of the effect of covid-19 on the optimal commitment of the healthcare professional. WATIs with MAPs, specialists in general medicine, pulmonologists, cardiologists and endocrinologists.
  • Analysis of concepts for a catalog of immunological treatments. Interviews with gastroenterologists and rheumatologists.
  • Study on non-alcoholic steatohepatitis, microbiome therapy and migraine therapy. Interviews with hepatologists, gastroenterologists, infectious disease specialists, neurologists, and general practitioners.
  • Study for understanding what are the unmet and/or under-served needs for patient interface masks used on patients receiving non-invasive ventilation (NIV) in the hospital. WATIs with nurses, department directors, Anaesthesiologists, Pulmonologists and Intensivists.
  • Treatment for invasive candidiasis and candidemia positioning Testing. WATI’s con médicos de enfermedades infecciosas, especialistas en UCI y oncohematólogos en España.
  • Test and optimization of concepts for the positioning of a brand of oral nutritional supplements (ONS). Focus groups rpesencailes with nutritionists, oncologists, geriatricians and internal medicine.
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH) study. Interviews with Pulmonologists, Cardiologists, Internal Medicine Specialist and Cardiothorasic Surgeons.
  • Understanding the management of patients with primary biliary cholangitis (PBC) treated with obeticholic acid, among gastroenterologists, hepatologists and internists
  • Study on the treatment of hyperlipidemia. Professional Advisory Groups with cardiologists, endocrinologists, internal medicine and GP’s
  • Pre-test of communication materials for the campaign to launch a statin for the treatment of cholesterol. Focus groups with internists and primary care physicians
  • Research to better understand the decision process around infusion delivery devices. 60 min WATIs with specialist doctors, family coordinators and administrators (biomedical managers, infusion coordinators, …)
  • Research for understanding the use of real world evidence data and information in order to help with monitoring drug outcomes and costs. WATIs with regional level payers.
  • Study to better understand the management of Covid-19 patients. TDI with generalist / primary care physicians, emergency (ER) Specialists, Senior Level payer and Point-of-care coordinator
  • Study about hypothetical treatments for pulmonary arterial hypertension (PAH). WATIs with payers and HCPs in Spain
  • Study about perceptions of the Alopecia Areata landscape and abaut a Unbranded Awareness Campaign. WATIs with regional and national payers in Spain.
  • Tardive dyskinesia study. Interviews with national and regional payers.
  • EU rheumatoid arthritis (RA) competitive pricing research, Interviews with payers.
    Evaluation of the benefits of a new drug for epilepsy.
  • Interviews with neurologists, epileptologists and payers.
    Study of therapies for Acutely Decompensated Heart Failure (ADHF). Interviews with Cardiology Department Head, Emergency Room Heads, AHF top Medical Experts (MEs), Hospital C-Level Executives and Exceptional funding source stakeholder
  • Study on a prodcuto for the treatment for FLT3 mutated AML (Acute Myeloid Leukaemia). Interviews with payers
  • Analysis of the positioning of a drug for Alzheimer’s disease. Interviews with payers.
  • Review of the new marketing strategy for a drug for kidney transplantation. Interviews with sales managers, product managers and medical managers
  • Evaluation of the assets of a new product profile for epilepsy. Interviews with neurologists, epileptologists and payers.
  • Study to understand the perceptions of information sources for flow cytometry, WATIs with Clinical / Medical Researchers and Post Doctorate / Junior Research Scientists.
  • Insights co-creation study for the new online platform of a pharmaceutical laboratory aimed at doctors. WATIs with urologists, dermatologists, hematologists, gastroenterologists, psychiatrists and infectious disease specialists.
  • Patient channel preference. WATIs with patients and caregivers of Chronic pain, Parkinson’s and related disorders, Benign Prostatic Hypertrophy, Prostate Cancer, Erectile dysfunction, Heart Failure, Sudden cardiac death, and Heart valve damage (needing replacement) WATI with patients and caregivers with chronic pain, Parkinson’s and related disorders, benign prostatic hypertrophy, prostate cancer, erectile dysfunction, heart failure, sudden cardiac death, and heart valve damage (need for replacement)
  • Pre-test of the health portal of a pharmaceutical laboratory aimed at health professionals. WATI of 60 min with oncologists, hematologists, cardiologists and rheumatologists.
  • Pre-test of the online portal of a pharmaceutical laboratory. WATI with oncologists, hematologists, cardiologists and rheumatologists.
  • Research for understanding the use of real world evidence data and information in order to help with monitoring drug outcomes and costs. WATIs with regional level payers.
  • Multicountry portability usability testing in UK, France, Germany, Italy and Spain. Video interviews with Pulmonologist and Pediatrician treatin Cystic Fibrosis patients.
  • Analysis of the training needs and online consultation of health professionals for the design of an online portal for a pharmaceutical laboratory and a digital strategy. WATI of 60 min with oncologists, hematologists, cardiologists and rheumatologists.
  • Analysis of the workshop on clinical informatics, with representatives of different hospitals, medical societies and institutions, within the international medical meeting “Hopes: better data better health” held in Barcelona
  • Evaluation of a new online platform of a pharmaceutical laboratory aimed at physicians. Online interviews with guided web browsing with urologists, endocrinologists, psychiatrists, dermatologists, hematologists, oncologists, gastroenterologists and rheumatologists.
  • Multicountry portability usability testing in UK, France, Germany, Italy and Spain. Video interviews with Pulmonologist and Pediatrician treatin Cystic Fibrosis patients.
  • Dialysis study. Interview with nephrologists and endocrinologists.
  • Diagnosis and quantification of the human erythropoietin (EPO) market in Nephrology. Interviews with transplant nephrologists
  • Evaluation of the benefits of a new drug for epilepsy. Interviews with neurologists, epileptologists and payers.
  • Study of the management and treatment of patients on hemodialysis suffering from chronic kidney disease (CKD) associated Pruritus. WATIs with hemo-dialysis nurses and patients
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Image study and positioning of an immunosuppressive treatment for transplants. Focus groups with nephrologists
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Refractory Generalized Myasthenia Gravis (gMG) Positioning Research with neurologists.
  • Study to evaluate the paying scenario for multiple sclerosis. Interviews with payers
  • Analysis of the positioning of a drug for Alzheimer’s disease. Interviews with payers.
  • Research on the positioning of drugs in the treatment of Alzheimer’s disease. Interviews with neurologists
  • Study on Parkinson’s. Coordination of the recruitment of neurologists
  • Study on non-alcoholic steatohepatitis, microbiome therapy and migraine therapy. Interviews with hepatologists, gastroenterologists, infectious disease specialists, neurologists, and general practitioners.
  • Opportunity Assessment: Anti-MOG Disease, with neurologists and Key Opinion Leaders
  • Study on multiple sclerosis. Coordination of the recruitment of neurologists attending the LIVE ECTRIMS Conference (European Committee for Treatment and Research in Multiple Sclerosis)
  • Study to understand acute contusional traumatic brain injury (TBI). WATIs with neurologists and neurosurgeons.
  • Study for understanding Controlled Access Programmes. WATIs with Hospital pharmacists from Neurology or paediatric neurology centres
  • Study for understanding acute contusional traumatic brain injury (TBI). WATIs with Neurologists and Neurosurgeons.
  • Exploring drivers and barriers to anti-CGRP use.
  • In-depth interviews with neurologists & headache / migraine specialists.
  • Study of the role played by the risk of progressive multifocal leukoencephalopathy (PML) and John Cunningham virus (JCV) in relation to the treatment of patients with highly active relapsing remitting multiple sclerosis (RRMS). WATIs with patients, laboratory directors, KOL pharmacists and neurologists
  • Study of the positioning of oral therapy in patients with multiple sclerosis. In-depth interviews with patients
  • Evaluation of the assets of a new product profile for epilepsy. Interviews with neurologists, epileptologists and payers.
  • Analysis of the care itinerary of patients with spinal muscular atrophy (SMA) type 1 and 2 with neuro-pediatricians.
  • Analysis of the care itinerary of patients with spinal muscular atrophy type 1 and 2, with neuro-pediatricians.
  • Study on the epidemiology of Spinal Cord Injury (SCI). Interviews with neurosurgeons and orthopedic surgeons.
  • Study to understand acute contusional traumatic brain injury (TBI). WATIs with neurologists and neurosurgeons.
  • Plaque psoriasis study. TDI with dermatologists, nurses and pharmacists.
  • Study to understand your views on current procedures and practices regarding the use of skin injection needles, among nurses, Policy (Safety / Risk / Quality) and Economic (Procurement / Tender Managers). 45 min WATI’s
  • Study of the management and treatment of patients on hemodialysis suffering from chronic kidney disease (CKD) associated Pruritus. WATIs with hemo-dialysis nurses and patients
  • Study for understanding what are the unmet and/or under-served needs for patient interface masks used on patients receiving non-invasive ventilation (NIV) in the hospital. WATIs with nurses, department directors, Anaesthesiologists, Pulmonologists and Intensivists.
  • Analysis of treatments for diabetic macular edema (DME) and intravitreal injections in Spain. WATIs with ophthalmologists specializing in the retina and responsible for administering IVT injections.
  • Study of the management and treatment of patients on hemodialysis suffering from chronic kidney disease (CKD) associated Pruritus. WATIs with hemo-dialysis nurses and patients
  • Evaluation of the benefits of a new drug for epilepsy. Interviews with neurologists, epileptologists and payers.
  • Evaluation of bupivacaine in Europe for postoperative pain relief. Interviews with pharmacists, surgeons and anesthesiologists.
  • Analysis of the osteoarticular pathology of the patient in Spain: structure and perceived quality. Interviews with social workers, care managers, nurses, occupational therapists, and gynecologists.
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Kids Growth malnutrition study. Online forum with parents of children with issue (or risk) of growth delay using a complete formula of oral nutritional supplement (ONS).
  • Test and optimization of concepts for the positioning of a brand of oral nutritional supplements (ONS). Focus groups rpesencailes with nutritionists, oncologists, geriatricians and internal medicine.
  • Study for better understand the needs and lifestyle of people with gum problems. Video interviews with patients and dentists
  • Study of oral health in people with diabetes in Spain. Interviews with patients and dentists
  • Study of renal cell carcinoma (RCC). Coordination of recruitment of caregivers and patients for entographical interviews
  • Test and optimization of concepts for the positioning of a brand of oral nutritional supplements (ONS). Focus groups rpesencailes with nutritionists, oncologists, geriatricians and internal medicine.
  • Study on motivations and emotional barriers in the prescription of drugs for metastatic breast cancer. Interviews with oncologists
  • Lymphoblastic leukemia study. Coordination of recruitment of oncologists
  • Study on a prodcuto for the treatment for FLT3 mutated AML (Acute Myeloid Leukaemia). Interviews with payers
  • Biosimilars study. Interviews with Oncologists, and Chief Hospital Pharmacists
  • Study of a new pharmaceutical option for the maintenance treatment of multiple myeloma. Interviews with oncologists.
  • Study of Interventional Oncology Ablation (IOA). Interviews with Interventional Radiologists specialists in oncology procedures, Interventional Radiologists generalists and Surgeons.
  • Study on recurrent ovarian cancer. Interviews with ongologists attending the ESMO 2018 Congress in Munich (Germany).
  • Prostate Cancer Campaign Effectiveness. WATIs with Urologists and Oncologists.
  • Bladder cancer drug demand assessment. TDIs with oncologists.
  • Concept testing research for a campaign development for Santen anti-infectives in ophthalmology , WATIs with ophthalmologists.
  • Concept test for an eye drop solution containing levofloxacin and dexamethasone. Computer-assisted telephone interviews with ophthalmologists who perform cataract surgery and cataract surgeons
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Concept Testing study (glaucoma treatment with prostaglandin analogs). WATIs with Ophthalmologists.
  • Retina patch study. WATIs with ophthalmic surgeons.
  • Analysis of treatments for diabetic macular edema (DME) and intravitreal injections in Spain. WATIs with ophthalmologists specializing in the retina and responsible for administering IVT injections.
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Analysis to determine the habits of pharmacists when dispensing products in the field of somatostatin analogs (SSA) market. TD’s de 60 min con farmacéuticos y mayoristas.
  • Research to better understand the decision process around infusion delivery devices. 60 min WATIs with specialist doctors, family coordinators and administrators (biomedical managers, infusion coordinators, …)
  • Biosimilars study. Interviews with Oncologists, and Chief Hospital Pharmacists
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH) study. Interviews with Pulmonologists, Cardiologists, Internal Medicine Specialist and Cardiothorasic Surgeons.
  • Study about hypothetical treatments for pulmonary arterial hypertension (PAH). WATIs with payers and HCPs in Spain
    Research on the optimal channel and content on idiopathic pulmonary fibrosis (IPF). 60 min WATIs with pulmonologists.
  • Study for understanding what are the unmet and/or under-served needs for patient interface masks used on patients receiving non-invasive ventilation (NIV) in the hospital. WATIs with nurses, department directors, Anaesthesiologists, Pulmonologists and Intensivists.
  • Study of the pseudomonas aeruginosa (PA) infections in patients with cystic fibrosis: relevance in clinical practice, management and treatment challenges. Online focus groups in Germany and UK with Pulmonogists
  • Study on the motivations to quit smoking. Interviews with ex-smokers of e-cigarettes / smokeless tobacco products and/or tobacco smokers.
  • Analysis of the effect of covid-19 on the optimal commitment of the healthcare professional. WATIs with GPs, specialists in general medicine, pulmonologists, cardiologists and endocrinologists.
  • Research on the second line of indication for a drug for major depressive disorders (MDD). Computer-assisted telephone interviews with psychiatrists.
  • Study on managing and treating patients diagnosed with Schizophrenia (SZ) who have had an inadequate response to treatment, specifically focussing on frustrated schizophrenia patients with breakthrough symptoms. Interviews with psychiatrists
  • Study for finding new ideas of services to psychiatrists. Online focus group with psychiatrists.
  • Analysis of treatment management for patients diagnosed with major depressive disorder (MDD) who have not responded adequately to antidepressants. In-depth interviews with psychiatrists and caregivers.
  • Study on major depression in adults. Expert forum with psychiatrists
  • Study for exploring nephropathic cystinosis universo. TDIs and videointerviews with patients, caregivers, Patient Association Group Representatives, Nephrologists/Paediatric nephrologists, Ophthalmologists, Endocrinologists, Gastroenterologists and Therapists.
  • Study on major depression in adults. Expert forum with psychiatrists
  • Study on glucocorticoid-induced osteoporosis (GCIOP). Coordination of the recruitment of rheumatologists
  • Study of Interventional Oncology Ablation (IOA). Interviews with Interventional Radiologists specialists in oncology procedures, Interventional Radiologists generalists and Surgeons.
  • Study on glucocorticoid-induced osteoporosis (GCIOP). Coordination of the recruitment of rheumatologists
  • EU rheumatoid arthritis (RA) competitive pricing research, Interviews with payers.
  • Exit Interviews in Phase 2 Clinical Trial in adults with Primary Sjögren’s Syndrome. IDI’s with Adults patients with Primary Sjögren’s Syndrome in Spain
  • Study on osteoporosis induced by glucorticoids. Coordination of the recruitment of rheumatologists
  • Analysis of the relationship between rheumatologists and pharmaceutical laboratories in order to achieve excellence in treatment. Interviews with rheumatologists.
  • Analysis of the importance of sustainability and relevance of the B Corp certification of a pharmaceutical laboratory. WATIs with healthcare professionals from Germany, the Netherlands, UK, France, Spain and Austria.
  • Study on surgery and prosthesis implantation. Orthopedic surgeon recruitment coordination
  • Study on advanced energy devices used in laparoscopic procedures. Recruitment coordination of operating room manager / director
  • Study of Interventional Oncology Ablation (IOA). Interviews with Interventional Radiologists specialists in oncology procedures, Interventional Radiologists generalists and Surgeons.
  • Evaluation of bupivacaine in Europe for postoperative pain relief. Interviews with pharmacists, surgeons and anesthesiologists.
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH) study. Interviews with Pulmonologists, Cardiologists, Internal Medicine Specialist and Cardiothorasic Surgeons.
  • Study on surgery and prosthesis implantation. Orthopedic surgeon recruitment coordination
  • Study on advanced energy devices used in laparoscopic procedures. Recruitment coordination of operating room manager / director
  • Review of the new marketing strategy for a drug for kidney transplantation. Interviews with sales managers, product managers and medical managers
  • Diagnosis and quantification of the human erythropoietin (EPO) market in Nephrology. Interviews with transplant nephrologists
  • Overactive Bladder (OAB) Study. Interviews with patients and professionals (GP/PCPs, Urologists, Gynecologists, Uro-Gynecologists, Prescribing Nurses, Physician’s Assistant,…).
  • Prostate Cancer Campaign Effectiveness. WATIs with Urologists and Oncologists.

Some of our clients

santen
bayer
novartis
jansen
gsk
roche
johnsons
bristolmyers

Experience in other sectors

FMCG
B2B
Third Sector
logoscambra
Victoria Scarpato Bravo has been a beneficiary of the European Regional Development Fund whose objective is to improve the use and quality of information and communication technologies and access to them and thanks to the implementation of the Web presence project through the page own. This action has taken place in the TICCámaras 2023 period. For this, it has had the support of the TICCámaras program of the Barcelona Chamber of Commerce.
logosxpande
Victoria Scarpato Bravo has been a beneficiary of the European Regional Development Fund whose objective is to improve the competitiveness of SMEs and thanks to which it has launched an International Digital Marketing Plan with the aim of improving its online positioning in foreign markets during the year 2023 For this, it has had the support of the XPANDE DIGITAL Program of the Barcelona Chamber of Commerce